Resources

Updated clinical practice guidelines jointly developed by the American Association of Clinical Endocrinologists (AACE) and the American Thyroid Association (ATA) regarding optimal evaluation, treatment and follow-up of patients with hypothyroidism have been released and are now available….

Nondiabetic patients who have elevated serum glucose levels when they are admitted to the hospital for community-acquired pneumonia (CAP) have an increased risk of dying within 90 days, compared with similar normoglycemic patients….

Steve Freed introduces Dr. Edelman who tells us about the Taking Control of Your Diabetes (TCOYD) programs which began in 1985 and now are up to 12 conventions a year, a TV show, a website, and a book, helping to bring diabetes education to millions of diabetes patients each year. More videos …

Dr. Steven V. Edelman discusses the results of a study he and his team did with patients to see how their perception of their blood sugars varied from their actual results. The results, he says, reinforce the idea of “Test, Don’t Guess.” Many patients said they could “feel” what their blood sugar was …

Dr. Edelman talks about how he believes that the diabetes doctor visit has to be redefined because the current way we interview patients is very inefficient. So he starts off each initial visit by asking the patient if they have any questions for him. This way the questions don’t get …

Dr. Edelman talks about the new healthcare and how Shared Medical Appointments (SMA’s) can make a huge difference in the efficiency of practices and the well-being of a patients. He has just received permission to begin using SMA’s in his own practice and has already set-up two groups, one for …

Dr. Edelman gives us an update on the TCOYD programs for 2012-2012 including; the fact that they are getting bigger each year with about 1500 people at each convention now; the type 1 track will be starting much earlier in the day this year with more special sessions; and the TCOYD …

Dr. Edelman gives us his thoughts on how the GLP-1 analogs have changed the way we practice, and why he thinks the GLP-1 drugs are the single most important advance for type 2 patients in recent years. He says that GLP-1’s are not being prescribed as much as they should be probably …

Hyperglycemia Hyperglycemia in DKA is the result of reduced glucose uptake and utilization from the liver, muscle, and fat tissue and increased gluconeogenesis as well as glycogenolysis. The lack of insulin results in an increase in gluconeogenesis, primarily in the liver but also in the kidney, and increased glycogenolysis in …

  In this week’s set of Homerun Slides, we explore how to approach treatment-induced wight gain and some of the medications that can help Type 2 diabetes patients control their weight while maintaining cardiovascular health….